Globus Medical Q4 EPS Beats by 20.8%, Revenues at $826M
Globus Medical reported adjusted EPS of $1.28 in Q4 2025, beating estimates by 20.8%, and revenue of $826 million, 4.9% above consensus. It holds a Zacks #1 rank after four consecutive quarters of earnings surprises averaging 13.2% and projects long-term EPS growth of 9.6% versus the industry’s 14%.
1. Q4 2025 Earnings and Revenue
Globus Medical’s Q4 2025 adjusted EPS of $1.28 surpassed consensus by 20.8%, while quarterly revenue reached $826 million, 4.9% above expectations. These results extend the company’s record of outperforming estimates and underscore robust demand across its implant and surgical solutions portfolio.
2. Zacks Ranking and Surprise Trend
The company maintains a Zacks #1 (Strong Buy) rank following four consecutive quarters of earnings surprises averaging 13.2%. This streak reflects both operational execution and conservative consensus estimates that the company has consistently outpaced.
3. Growth Outlook and Industry Comparison
Analysts project long-term EPS growth of 9.6% for Globus Medical, below the med-tech industry’s 14% average, highlighting a moderate expansion profile. While the growth rate trails peers, the company’s strong margin performance and recurring revenue streams support a steady upward trajectory.